India · Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 101.32 billion. The enterprise value is 117.72 billion.
| Market Cap | 101.32B |
| Enterprise Value | 117.72B |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 141.00 million shares outstanding. The number of shares has increased by 0.88% in one year.
| Current Share Class | 141.00M |
| Shares Outstanding | 141.00M |
| Shares Change (YoY) | +0.88% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 11.57% |
| Owned by Institutions (%) | 24.15% |
| Float | 48.77M |
Valuation Ratios
The trailing PE ratio is 287.96 and the forward PE ratio is 83.72.
| PE Ratio | 287.96 |
| Forward PE | 83.72 |
| PS Ratio | 4.22 |
| PB Ratio | 10.20 |
| P/TBV Ratio | 22.53 |
| P/FCF Ratio | 68.12 |
| P/OCF Ratio | 26.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.54, with an EV/FCF ratio of 79.15.
| EV / Earnings | 332.91 |
| EV / Sales | 4.90 |
| EV / EBITDA | 27.54 |
| EV / EBIT | 59.49 |
| EV / FCF | 79.15 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.78.
| Current Ratio | 0.73 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.78 |
| Debt / EBITDA | 4.15 |
| Debt / FCF | 11.89 |
| Interest Coverage | 1.20 |
Financial Efficiency
Return on equity (ROE) is 4.33% and return on invested capital (ROIC) is 4.69%.
| Return on Equity (ROE) | 4.33% |
| Return on Assets (ROA) | 3.68% |
| Return on Invested Capital (ROIC) | 4.69% |
| Return on Capital Employed (ROCE) | 7.70% |
| Revenue Per Employee | 3.57M |
| Profits Per Employee | 52,494 |
| Employee Count | 6,736 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 20.78 |
Taxes
In the past 12 months, NSE:HCG has paid 9.00 million in taxes.
| Income Tax | 9.00M |
| Effective Tax Rate | 2.14% |
Stock Price Statistics
The stock price has increased by +39.78% in the last 52 weeks. The beta is -0.27, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | -0.27 |
| 52-Week Price Change | +39.78% |
| 50-Day Moving Average | 714.27 |
| 200-Day Moving Average | 609.18 |
| Relative Strength Index (RSI) | 43.72 |
| Average Volume (20 Days) | 181,427 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 24.04 billion and earned 353.60 million in profits. Earnings per share was 2.50.
| Revenue | 24.04B |
| Gross Profit | 12.49B |
| Operating Income | 1.96B |
| Pretax Income | 420.64M |
| Net Income | 353.60M |
| EBITDA | 3.55B |
| EBIT | 1.96B |
| Earnings Per Share (EPS) | 2.50 |
Balance Sheet
The company has 2.02 billion in cash and 17.68 billion in debt, giving a net cash position of -15.66 billion or -111.08 per share.
| Cash & Cash Equivalents | 2.02B |
| Total Debt | 17.68B |
| Net Cash | -15.66B |
| Net Cash Per Share | -111.08 |
| Equity (Book Value) | 9.94B |
| Book Value Per Share | 65.64 |
| Working Capital | -2.76B |
Cash Flow
In the last 12 months, operating cash flow was 3.83 billion and capital expenditures -2.35 billion, giving a free cash flow of 1.49 billion.
| Operating Cash Flow | 3.83B |
| Capital Expenditures | -2.35B |
| Free Cash Flow | 1.49B |
| FCF Per Share | 10.55 |
Margins
Gross margin is 51.97%, with operating and profit margins of 8.16% and 1.47%.
| Gross Margin | 51.97% |
| Operating Margin | 8.16% |
| Pretax Margin | 1.75% |
| Profit Margin | 1.47% |
| EBITDA Margin | 14.77% |
| EBIT Margin | 8.16% |
| FCF Margin | 6.19% |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.88% |
| Shareholder Yield | -0.88% |
| Earnings Yield | 0.35% |
| FCF Yield | 1.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |